Mice with orthotopic transplants of metastatic MYC/Twist1-HCC were treated either with control antibody, or anti-Ccl2 antibody alone or anti-Il13 antibody alone or their combination for 4 weeks (Figure 7a). The gene discussed is CCL2; the disease is hepatocellular carcinoma.